Valeo Pharma Inc
TSX:VPH
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value of VPH.
The Intrinsic Value is calculated as the average of DCF and Relative values:
| FR |
|
Pharnext SCA
OTC:PNEXF
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Valeo Pharma Inc
Balance Sheet Decomposition
Valeo Pharma Inc
| Current Assets | 19.1m |
| Cash & Short-Term Investments | 7.1m |
| Receivables | 4.8m |
| Other Current Assets | 7.2m |
| Non-Current Assets | 13.1m |
| PP&E | 2.5m |
| Intangibles | 10.7m |
| Current Liabilities | 69.9m |
| Accounts Payable | 18.7m |
| Short-Term Debt | 3.4m |
| Other Current Liabilities | 47.8m |
| Non-Current Liabilities | 25.3m |
| Long-Term Debt | 24.4m |
| Other Non-Current Liabilities | 880k |
Free Cash Flow Analysis
Valeo Pharma Inc
| CAD | |
| Free Cash Flow | CAD |
Earnings Waterfall
Valeo Pharma Inc
|
Revenue
|
53.4m
CAD
|
|
Cost of Revenue
|
-44.6m
CAD
|
|
Gross Profit
|
8.8m
CAD
|
|
Operating Expenses
|
-27.9m
CAD
|
|
Operating Income
|
-19.1m
CAD
|
|
Other Expenses
|
-13m
CAD
|
|
Net Income
|
-32.1m
CAD
|
VPH Profitability Score
Profitability Due Diligence
Valeo Pharma Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
Score
Valeo Pharma Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
VPH Solvency Score
Solvency Due Diligence
Valeo Pharma Inc's solvency score is 21/100. The higher the solvency score, the more solvent the company is.
Score
Valeo Pharma Inc's solvency score is 21/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
VPH Price Targets Summary
Valeo Pharma Inc
Dividends
Current shareholder yield for
VPH is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?